TD Cowen analyst Tyler Van Buren assigned a Buy rating on Travere Therapeutics (TVTX – Research Report) today and set a price target of ...
TD Cowen adjusted its outlook on Regeneron Pharmaceuticals, with analyst Tyler Van Buren revising the price target to $1,030 ...
TD Cowen analyst Tyler Van Buren maintained a Buy rating on BridgeBio Pharma (BBIO – Research Report) today. The company’s shares closed last ...
Q4 2024 Management View CEO Leonard Schleifer highlighted 10% revenue growth in Q4 2024, attributed to strong performance from Dupixent, Libtayo, and EYLEA HD. He emphasized the acceleration in EYLEA ...
TimesMachine is an exclusive benefit for home delivery and digital subscribers. About the Archive This is a digitized version of an article from The Times’s print archive, before the start of ...
TD Cowen analyst Tyler Van Buren initiated coverage of CG Oncology (CGON) with a Buy rating and no price target The firm says cretostimogene is differentiated by its “superior” efficacy and ...
Martin Van Buren allied himself with President Andrew ... with his opponent William Harrison's slogan ("Tippecanoe and Tyler Too"), scandalous assertions about his vice president's sexual tastes ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback